Adverum Biotechnologies, Inc.

Historical 13F Holders

Symbol
ADVM
CUSIP
00773U108
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q4 66 68.7 M $51.7 M
2023 Q3 66 65.3 M $97.9 M
2023 Q2 60 65.7 M $104 M
2023 Q1 58 62.7 M $45.0 M
2022 Q4 67 57.6 M $33.4 M
2022 Q3 83 58.5 M $55.6 M
2022 Q2 81 58.2 M $70.0 M
2022 Q1 99 63.6 M $86.4 M
2021 Q4 112 66.1 M $119 M
2021 Q3 121 70.0 M $155 M
2021 Q2 131 79.2 M $280 M
2021 Q1 140 95.1 M $938 M
2020 Q4 172 96.1 M $1.04 B
2020 Q3 175 95.2 M $980 M
2020 Q2 156 80.9 M $1.69 B
2020 Q1 139 80.8 M $790 M
2019 Q4 129 60.9 M $702 M
2019 Q3 115 49.0 M $267 M
2019 Q2 102 46.4 M $549 M
2019 Q1 85 39.7 M $208 M
2018 Q4 89 39.1 M $123 M
2018 Q3 111 35.3 M $274 M
2018 Q2 107 37.0 M $196 M
2018 Q1 102 34.9 M $202 M
2017 Q4 68 19.2 M $67.3 M
2017 Q3 58 13.6 M $49.5 M
2017 Q2 63 13.0 M $32.5 M
2017 Q1 78 13.9 M $37.4 M
2016 Q4 85 15.2 M $44.0 M
2016 Q3 78 15.3 M $62.7 M
2016 Q2 78 15.8 M $49.8 M
2016 Q1 3 226 k $1.17 M